The global mRNA synthesis raw material market was valued at USD 1.70 billion in 2024, projected to reach USD 2.67 billion by 2032 with a CAGR of 5.81%. The US led with USD 0.57 billion in 2024 due to investments in mRNA vaccine and therapeutics. Demand is driven by mRNA-based vaccines and treatments for various diseases.

Pharmaceutical and biopharmaceutical companies dominated the end-use segment with a 48.5% market revenue contribution in 2024. The market for Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) is growing rapidly as biotech startups outsource mRNA development. North America led the market in 2024, with Asia Pacific as the fastest-growing region.

In January 2025, Thermo Fisher Scientific launched a new GMP-compliant IVT kit to enhance scalability in mRNA manufacturing. BioNTech announced a USD 1.07 billion expansion of its Marburg facility in April 2025 to reduce reliance on third-party suppliers. R&D investment trends, manufacturing capacity by region, spending by funding source, pricing trends of raw materials, and supply chain strategies are key sections of the report. The mRNA Synthesis Raw Materials Market Report projects market size to reach USD 2.67 billion by 2032 with a CAGR of 5.81% from 2025 to 2032. Key segments include capping agents, nucleotides, plasmid DNA, enzymes, and more. Applications span vaccine production, therapeutics, and more, targeting various industries globally.

Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Access the complete report for in-depth analysis and outlook on the mRNA Synthesis Raw Materials Market. For customization or further information, contact [email protected]. SNS Insider provides market research and consulting services globally, offering valuable insights to help clients navigate changing market conditions. Utilizing various research techniques, we deliver accurate data and consumer opinions to support confident decision-making.

Read more at GlobeNewswire: mRNA Synthesis Raw Materials Market to Reach USD 2.67